These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25772745)

  • 81. Impact of cigarette minimum price laws on the retail price of cigarettes in the USA.
    Tynan MA; Ribisl KM; Loomis BR
    Tob Control; 2013 May; 22(e1):e78-85. PubMed ID: 22863888
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Why stents are expensive: Drivers of high prices in emerging markets.
    Pandey N; Thombal AE
    Health Mark Q; 2018; 35(4):298-312. PubMed ID: 30596465
    [TBL] [Abstract][Full Text] [Related]  

  • 83. What are the main drivers of the Bitcoin price? Evidence from wavelet coherence analysis.
    Kristoufek L
    PLoS One; 2015; 10(4):e0123923. PubMed ID: 25874694
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The effect of injecting price competition into the hospital market: the case of preferred provider organizations.
    Dranove D; Satterthwaite M; Sindelar J
    Inquiry; 1986; 23(4):419-31. PubMed ID: 2947862
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Economic burden of atopic manifestations in patients with atopic dermatitis--analysis of administrative claims.
    Suh DC; Sung J; Gause D; Raut M; Huang J; Choi IS
    J Manag Care Pharm; 2007; 13(9):778-89. PubMed ID: 18062729
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Use of insurance claims data in measuring quality of care.
    Lohr KN
    Int J Technol Assess Health Care; 1990; 6(2):263-71. PubMed ID: 2203702
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Process evaluation of health system costing - Experience from CHSI study in India.
    Prinja S; Brar S; Singh MP; Rajsekhar K; Sachin O; Naik J; Singh M; Tomar H; ; Bahuguna P; Guinness L
    PLoS One; 2020; 15(5):e0232873. PubMed ID: 32401763
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
    Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
    J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings.
    Russo G; McPake B
    Health Policy Plan; 2010 Jan; 25(1):70-84. PubMed ID: 19843636
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Regulating Hospital Prices Based On Market Concentration Is Likely To Leave High-Price Hospitals Unaffected.
    Pany MJ; Chernew ME; Dafny LS
    Health Aff (Millwood); 2021 Sep; 40(9):1386-1394. PubMed ID: 34495728
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Making markets work for disability services: The question of price setting.
    Carey G; Malbon ER; Weier M; Dickinson H; Duff G
    Health Soc Care Community; 2019 Sep; 27(5):e716-e723. PubMed ID: 31215103
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Does Competition Have an Effect on Price and Quality in Physiotherapy?
    Pekola P; Linnosmaa I; Mikkola H
    Health Econ; 2017 Oct; 26(10):1278-1290. PubMed ID: 27619843
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The price effect of hospital closures.
    Wu VY
    Inquiry; 2008; 45(3):280-92. PubMed ID: 19069010
    [TBL] [Abstract][Full Text] [Related]  

  • 95. China's medical savings accounts: an analysis of the price elasticity of demand for health care.
    Yu H
    Eur J Health Econ; 2017 Jul; 18(6):773-785. PubMed ID: 27650358
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prices need no preferences: social trends determine decisions in experimental markets for pain relief.
    Vlaev I; Seymour B; Chater N; Winston JS; Yoshida W; Wright N; Symmonds M; Dolan R
    Health Psychol; 2014 Jan; 33(1):66-76. PubMed ID: 23148449
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Predictability of machine learning techniques to forecast the trends of market index prices: Hypothesis testing for the Korean stock markets.
    Pyo S; Lee J; Cha M; Jang H
    PLoS One; 2017; 12(11):e0188107. PubMed ID: 29136004
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Forecasting Financial Extremes: A Network Degree Measure of Super-Exponential Growth.
    Yan W; van Tuyll van Serooskerken E
    PLoS One; 2015; 10(9):e0128908. PubMed ID: 26339793
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Unraveling hidden order in the dynamics of developed and emerging markets.
    Berman Y; Shapira Y; Ben-Jacob E
    PLoS One; 2014; 9(11):e112427. PubMed ID: 25383630
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Price and distribution policies in healthcare marketing in Romania.
    Coculescu BI; Coculescu EC; Purcărea VL
    J Med Life; 2017; 10(2):144-146. PubMed ID: 28616091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.